Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Assets Average (2020 - 2026)

Alx Oncology Holdings' Assets Average history spans 4 years, with the latest figure at $231.3 million for Q4 2023.

  • On a quarterly basis, Assets Average fell 25.88% to $231.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was $231.3 million, a 25.88% decrease, with the full-year FY2023 number at $274.5 million, down 20.04% from a year prior.
  • Assets Average hit $231.3 million in Q4 2023 for Alx Oncology Holdings, down from $233.0 million in the prior quarter.
  • Over the last five years, Assets Average for ALXO hit a ceiling of $434.5 million in Q1 2021 and a floor of $182.8 million in Q3 2020.
  • Historically, Assets Average has averaged $327.4 million across 4 years, with a median of $340.6 million in 2020.
  • Biggest five-year swings in Assets Average: skyrocketed 124.59% in 2021 and later fell 29.78% in 2023.
  • Tracing ALXO's Assets Average over 4 years: stood at $349.3 million in 2020, then rose by 11.65% to $390.0 million in 2021, then dropped by 19.97% to $312.1 million in 2022, then decreased by 25.88% to $231.3 million in 2023.
  • Business Quant data shows Assets Average for ALXO at $231.3 million in Q4 2023, $233.0 million in Q3 2023, and $262.0 million in Q2 2023.